gene therapy in cardiovascular diseases asan … therapy.pdf · gene therapy in cardiovascular...
Post on 01-Oct-2020
2 Views
Preview:
TRANSCRIPT
GENE THERAPY IN CARDIOVASCULAR DISEASES
ASAN MEDICAL CENTERKI HOON HAN MD
GENE THERAPY
1. CORRECT GENES
2. CURE WITH GENES
WHAT IS GENE ?
DNA ( deoxyribonucleic acid )- DOUBLE HELICAL STRUCTURE
GENE ; PART OF DNA THAT LEADS TO EXPRESSION
gene genegene
WHAT IS GENE ?
DNA ( deoxyribonucleic acid )-Double helical structure
- IN THE NUCLEUS
WHAT IS GENE ?
DNA ( deoxyribonucleic acid )- present as allele
WHAT IS GENE ?
DNA ( deoxyribonucleic acid )- each allele is from father and mother
+ = 2n
WRINKLED AND STRAIGHT HAIR
CENTRAL DOGMA
RNAprotein
GENE DISEASE
ABNORMALPROTEIN
ABNORMAL GENE
NORMALPROTEIN CURE
Gene (DNA)
CORRECTION
SICKLE CELL ANEMIA
BLESSED OR BUSTED ?
NATURAL SELECTION
NORMAL RBC – TARGET OF MALARIASSA - TOLERANT AGAINST MALARIA
NORMAL ENVIRONMENTNO SSA
ENDEMIC FOR MALARIASSA FAVORED
GENE THERAPY
1. CORRECT GENES
2. CURE WITH GENES
RNAprotein
ABNORMALGene (DNA)
RNAABNORMAL
proteinGene (DNA)
Gene (DNA)정상Gene (DNA)
Gene (DNA)
GENE THERAPY
GENE IN CARRIER
TO NUCLEUS
Oh! VIRUS
GENE THERAPY IN CARDIOVASCULAR DISEASES
ANGIOGENESISHEART FAILURE
Ex) cystic fibrosis, Duchenne’s muscular dystrophy
ANGIOGENESIS
Pathologic condition(Ischemia)
failed
OperationManageable
Intervention
Un - Manageable“ no option patient “
Gene therapy
Gene Therapy in Cardiovascular System
Improved in myocardial perfusion in ischemic heart disease
Reduced failure of lower extremity bypass grafts
Limb salvage in patients recommended for lower extremity amputation
Resolution of sensory deficits in patients with ischemicperipheral neuropathy
Mode of Delivery
Improved in Myocardial Perfusion in Ischemic Heart Disease
Isner et alCirculation 1998;98:2800
Lim
b sa
lvag
e in
pat
ient
s rec
omm
ende
d fo
r lo
wer
ext
rem
ity a
mpu
tatio
n
Isner et alCirculation 1998;97:1114
VEGF (vascular endothelial growth factor)
- Discovered by N. Ferrara in 1986, 45 kDa- subsets of VEGF in human
VEGF 121VEGF 165VEGF 189
- VEGF receptors
VEGFR-1 ; Flt-1VEGFR-2 ; KDR/Flk-1VEGFR-3 ; Flt-4
Exon 1-5
Exon 6 7 8
VEGF is induced by ----
Haemodynamicsexercisehyperthyroid statedrugs
Shear stress and stretch on the myocardiumHypoxiaInflammatory responses
Fibroblast growth factor-2 (Basic fibroblast growth factor); 18 kDa
Fibroblast growth factor-1 (Acidic fibroblast growth factor); 16 kDa
- induces proliferation in wide range of cells upon various stimuli such as hypoxia
- control of capillary proliferation during embryogenesis, tumour progression, and wound healing.
Pitfall of Gene Therapy in Cardiovascular system
High Mortality ?
High Morbidity ?
Mortality
- procedural deaths or any deaths attributable to the transgene used.?
; negligible
- d/t the grim prognosis of the patients included in the study ?; yes
Morbidity
Accelerated AtherosclerosisVascular MalformationsNeoplasmsRetinopathyEdemaAdditional Safety Concerns
HypotensionArrhythmias
FUTURE
- More study to elucidate the detailed mechanisms of angiogenesis- Clarify the safety and accuracy of the current methods of gene delivery- Confirm the long term effect of gene therapy in angiogenesis- Consider the transport of more than one gene to expect the synergistic effect - Be aggressive to fulfill the phase 3 trials !
Angiopoietin-2 - loosening smooth muscle cellsVEGF - growth of endothelial cellsephrin-B2 - morphological arterializationAngiopoietin-1 - growth of smooth muscle cells
MYOPATHY ;MORE DIFFICULTCELL THERAPY IS FAVORED, BUT NOT READY
YEAR 2053 ?
TREATMENT OF ISCHEMIC HEART DISEASE
= ANGIOGENESIS WITH GENE THERAPY+
MYOCARDIAL REGENERATION WITH CELL THERAPY
top related